PJT Stock Analysis: PJT | NYSE
Capital Markets | NYSE, USA | Market Cap: 6.650m USD | 12M Return: -0.7% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 71.6M
EPS Trend: 96.8%
Qual. Beats: 0
Rev. Trend: 99.2%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
PJT Partners Inc. is a New York-based investment bank that provides strategic advisory, shareholder advisory, capital markets advisory, and restructuring services to corporations, financial sponsors, institutional investors, and governments worldwide. The firm was incorporated in 2014 and spun off from Blackstone in 2015, when it was renamed from Blackstone Advisory Inc. and subsequently listed on the NYSE in October 2015.
The companys advisory work spans mergers and acquisitions (including spin-offs, activism defense, contested M&A, joint ventures, and divestitures), debt and equity capital markets transactions such as IPOs and acquisition financings, and liability management and Chapter 11 restructurings. It also offers private fund advisory and fundraising services, as well as a dedicated geopolitical and policy advisory practice that supports corporate boards and management teams in navigating shifting international relationships.
As a member of the Financials sector and the Investment Banking & Brokerage sub-industry, PJT operates a fee-based advisory model in which revenue is typically driven by retainer and transaction-related fees tied to the size and completion of client engagements, rather than balance sheet exposure.
- M&A advisory revenue tracks global deal pipeline recovery
- Restructuring mandates rise amid corporate debt stress
- Compensation expense ratio remains key margin pressure
| Net Income: 186.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.39 > 0.02 and ΔFCF/TA 4.28 > 1.0 |
| NWC/Revenue: 31.92% < 20% (prev 29.79%; Δ 2.13% < -1%) |
| CFO/TA 0.43 > 3% & CFO 666.5m > Net Income 186.6m |
| Net Debt (112.7m) to EBITDA (412.3m): 0.27 < 3 |
| Current Ratio: 8.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (28.6m) vs 12m ago -35.65% < -2% |
| Gross Margin: 47.95% > 18% (prev 31.18%; Δ 16.77% > 0.5%) |
| Asset Turnover: 122.1% > 50% (prev 106.6%; Δ 15.54% > 0%) |
| Interest Coverage Ratio: 27.59 > 6 (EBIT TTM 384.7m / Interest Expense TTM 13.9m) |
| A: 0.37 (Total Current Assets 657.7m - Total Current Liabilities 80.8m) / Total Assets 1.56b |
| B: 0.28 (Retained Earnings 438.2m / Total Assets 1.56b) |
| C: 0.26 (EBIT TTM 384.7m / Avg Total Assets 1.48b) |
| D: 0.43 (Book Value of Equity 272.7m / Total Liabilities 634.1m) |
| Altman-Z'' = 5.53 = AAA |
| DSRI: 0.85 (Receivables 348.9m/338.6m, Revenue 1.81b/1.49b) |
| GMI: 0.65 (GM 31.18% / 47.95%) |
| AQI: 0.89 (AQ_t 0.32 / AQ_t-1 0.35) |
| SGI: 1.21 (Revenue 1.81b / 1.49b) |
| TATA: -0.31 (NI 186.6m - CFO 666.5m) / TA 1.56b) |
| Beneish M = -3.41 (Cap -4..+1) = AA |
As of July 08, 2026, the stock is trading at USD 168.56 with a total of 422,045 shares traded. Over the past week, the price has changed by +16.24%, over one month by +7.17%, over three months by +19.19% and over the past year by -0.73%.
Current recommended Stop Loss: 158.00 (which is 6.3% or 1.7 ATR below the current price).
PJT has received a consensus analysts rating of 2.67. Therefore, it is recommended to hold PJT.
- StrongBuy: 0
- Buy: 0
- Hold: 5
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 169.8 | 0.7% |
P/E Trailing = 23.656
P/E Forward = 21.2766
P/S = 3.6815
P/B = 15.4335
P/EG = 1.36
Revenue TTM = 1.81b USD
EBIT TTM = 384.7m USD
EBITDA TTM = 412.3m USD
Long Term Debt = unknown (none)
Short Term Debt = 35.8m USD (from shortTermDebt, last fiscal year)
Debt = 421.5m USD (from shortLongTermDebtTotal, last quarter) (leases 421.5m already included)
Net Debt = 112.7m USD (calculated: Debt 421.5m - CCE 308.8m)
Enterprise Value = 6.76b USD (6.65b + Debt 421.5m - CCE 308.8m)
Interest Coverage Ratio = 27.59 (Ebit TTM 384.7m / Interest Expense TTM 13.9m)
EV/FCF = 11.01x (Enterprise Value 6.76b / FCF TTM 614.4m)
FCF Yield = 9.08% (FCF TTM 614.4m / Enterprise Value 6.76b)
FCF Margin = 33.99% (FCF TTM 614.4m / Revenue TTM 1.81b)
Net Margin = 10.32% (Net Income TTM 186.6m / Revenue TTM 1.81b)
Gross Margin = 47.95% ((Revenue TTM 1.81b - Cost of Revenue TTM 940.8m) / Revenue TTM)
Gross Margin QoQ = none% (prev 33.36%)
Tobins Q-Ratio = 4.32 (Enterprise Value 6.76b / Total Assets 1.56b)
Interest Expense / Debt = 3.31% (Interest Expense 13.9m / Debt 421.5m)
Taxrate = 12.38% (45.9m / 370.7m)
NOPAT = 337.0m (EBIT 384.7m * (1 - 12.38%))
Current Ratio = 8.14 (Total Current Assets 657.7m / Total Current Liabilities 80.8m)
Debt / Equity = 1.55 (Debt 421.5m / totalStockholderEquity, last quarter 272.7m)
Debt / EBITDA = 0.27 (Net Debt 112.7m / EBITDA 412.3m)
Debt / FCF = 0.18 (Net Debt 112.7m / FCF TTM 614.4m)
Total Stockholder Equity = 244.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 12.61% (Net Income 186.6m / Total Assets 1.56b)
RoE = 76.40% (Net Income TTM 186.6m / Total Stockholder Equity 244.3m)
RoCE = 25.94% (EBIT 384.7m / Capital Employed (Total Assets 1.56b - Current Liab 80.8m))
RoIC = 23.60% (NOPAT 337.0m / Invested Capital 1.43b)
WACC = 10.17% (E(6.65b)/V(7.07b) * Re(10.63%) + D(421.5m)/V(7.07b) * Rd(3.31%) * (1-Tc(0.12)))
Discount Rate = 10.63% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 2.22 | Cagr: 5.50%
[DCF] Terminal Value 72.32% ; FCFF base≈564.2m ; Y1≈646.7m ; Y5≈951.8m
[DCF] Fair Price = 415.4 (EV 10.8b - Net Debt 112.7m = Equity 10.7b / Shares 25.8m; r=10.17% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 96.76 | EPS CAGR: 36.35% | SUE: 0.04 | # QB: 0
Revenue Correlation: 99.18 | Revenue CAGR: 20.68% | SUE: 0.05 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.62 | Chg30d=-0.96% | Revisions=+0% | Analysts=7
EPS next Quarter (2026-09-30): EPS=1.81 | Chg30d=-1.71% | Revisions=-62% | Analysts=6
EPS current Year (2026-12-31): EPS=7.52 | Chg30d=+0.00% | Revisions=+10% | GrowthEPS=+7.8% | GrowthRev=+9.2%
EPS next Year (2027-12-31): EPS=8.55 | Chg30d=-0.08% | Revisions=+29% | GrowthEPS=+13.6% | GrowthRev=+10.5%
[Analyst] Revisions Ratio: -8% (up=10, down=12)